Lifecore Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 2, 2026	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022	May '21 May 30, 2021
Market Cap	144	249	172	241	291	351
Market Cap Growth	-41.55%	44.86%	-28.66%	-17.35%	-17.04%	12.60%
Enterprise Value	270.17	413.65	329.61	371.76	337.96	564.22
Last Close Price	3.84	6.72	5.62	7.94	9.87	11.97
PE Ratio	-	-5.29	17.03	-2.39	-2.49	-10.88
Forward PE	-	-	25.55	-	-	-
PEG Ratio	-	0.92	0.92	0.92	0.92	0.92
PS Ratio	1.11	1.93	1.34	2.33	2.62	3.48
PB Ratio	4.23	186.24	15.18	-56.92	3.32	1.73
P/TBV Ratio	-9.41	175.14	18.21	-56.23	3.31	1.73
P/FCF Ratio	23.10	-18.27	-9.47	-6.19	-5.54	-40.12
P/OCF Ratio	11.45	-1207.85	668.34	-13.80	-12.89	21.32
EV/Sales Ratio	2.09	3.21	2.57	3.60	3.04	5.59
EV/EBITDA Ratio	32.78	-44.87	-370.35	-43.13	53.90	51.09
EV/EBIT Ratio	-	-23.99	-37.27	-17.06	-28.66	-63.95
EV/FCF Ratio	43.37	-30.37	-18.17	-9.55	-6.43	-64.47
Debt / Equity Ratio	-9.95	95.06	10.93	-26.19	0.54	1.06
Debt / EBITDA Ratio	-15.33	-13.78	-139.02	-13.07	23.96	19.55
Debt / FCF Ratio	-10.37	-9.32	-6.82	-2.89	-2.86	-24.66
Net Debt / Equity Ratio	-8.72	88.87	10.19	-22.11	1.70	1.06
Net Debt / EBITDA Ratio	-13.43	-12.88	-129.51	-10.85	23.80	19.44
Net Debt / FCF Ratio	-9.09	-8.72	-6.35	-2.40	-2.84	-24.53
Asset Turnover	0.53	0.52	0.51	0.39	0.29	0.19
Inventory Turnover	2.59	2.45	2.14	1.96	1.46	0.96
Quick Ratio	2.18	1.72	1.02	1.22	0.22	0.42
Current Ratio	3.49	2.84	2.08	2.39	0.66	1.46
Return on Equity (ROE)	-6195.83%	-610.72%	273.73%	-152.21%	-17.82%	-16.66%
Return on Assets (ROA)	-7.07%	-6.98%	-3.55%	-8.21%	-3.80%	-2.05%
Return on Invested Capital (ROIC)	-8.45%	-8.45%	-4.42%	-9.72%	-4.11%	-2.27%
Return on Capital Employed (ROCE)	-8.05%	-8.13%	-4.12%	-13.95%	-4.72%	-2.27%
Earnings Yield	-23.98%	-18.90%	5.87%	-41.81%	-40.22%	-9.19%
FCF Yield	4.33%	-5.47%	-10.56%	-16.17%	-18.03%	-2.49%
Buyback Yield / Dilution	-1.63%	5.02%	-22.37%	-1.67%	-0.59%	-0.45%
Total Shareholder Return	-1.63%	5.02%	-22.37%	-1.67%	-0.59%	-0.45%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q